August 2023

SPOTLIGHT ON

New analysis shows no correlation between glycol ethers & endocrine disruption

The Glycol Ethers group has contributed to a publication on the available literature and data concerning the endocrine-disrupting properties of P-series glycol ethers (PGE). The article, titled “Propylene Oxide Derived Glycol Ethers: A Review of the Potential of Alkyl Glycol Ethers to Cause Endocrine Disruption,” was recently published in the journal “Regulatory Toxicology and Pharmacology.” The extensive analysis revealed no significant evidence to support other published claims that PGE target endocrine organs or perturb endocrine pathways.

Access the Glycol Ethers P series ED review